BioRestorative Therapies, Inc.

A clinical-stage company developing stem cell therapies for pain, metabolic disorders, and aesthetics.

BRTX | US

Overview

Corporate Details

ISIN(s):: US0906556065
LEI:
Country:: United States of America
Address:: 40 MARCUS DRIVE, 11747 MELVILLE
Website:: https://www.biorestorative.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

BioRestorative Therapies, Inc. is a clinical-stage regenerative medicine company focused on developing therapeutic products using advanced cell and tissue protocols, primarily involving adult stem cells. The company's lead clinical program centers on BRTX-100, an investigational single-dose therapy derived from bone marrow mesenchymal stem cells, which is in a Phase 2 trial for treating chronic lumbar disc disease. In addition to addressing chronic pain, BioRestorative is developing a pipeline of brown adipose-derived stem cell therapies for metabolic disorders. The company also has a commercial-facing BioCosmeceutical platform that leverages its secretome and exosome-based biologics for applications in aesthetic medicine.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all BioRestorative Therapies, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for BioRestorative Therapies, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for BioRestorative Therapies, Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
JOHNSON & JOHNSON Develops innovative medicines and medical technologies for complex diseases and personalized care.	United States of America	JNJ
Journey Medical Corp A pharmaceutical firm commercializing prescription drugs and generics for dermatology.	United States of America	DERM
JUPITER NEUROSCIENCES, INC. Pharma firm developing resveratrol treatments for neuroinflammation and rare diseases.	United States of America	JUNS
JW LIFESCIENCE CORPORATION A leading developer and manufacturer of infusion solutions, from basic IV fluids to complex nutrients.	South Korea	234080
JW SHINYAK CORPORATION Develops specialty medicines for the dermatology, urology, and otolaryngology clinical markets.	South Korea	067290
Jyong Biotech Ltd. Develops plant-derived drugs for urinary system diseases, with a lead candidate in Phase III trials.	United States of America	MENS
Kadimastem Ltd. Develops off-the-shelf stem cell therapies for diabetes & neurodegenerative diseases.	Israel	KDST
kainos loboratories,inc Develops, manufactures, and sells innovative clinical diagnostic reagents for the healthcare industry.	Japan	4556
Kairos Pharma, LTD. Develops novel oncology therapies to reverse drug resistance and immune suppression.	United States of America	KAPA
KAKEN PHARMACEUTIAL CO., LTD. R&D pharma firm creating drugs & devices for orthopedics, dermatology, and surgery globally.	Japan	4521